Accéder au contenu
Merck

A review of prednicarbate (Dermatop).

Skin therapy letter (2005-01-20)
A K Gupta, M Chow
RÉSUMÉ

Prednicarbate is a nonhalogenated corticosteroid that is used in the treatment of inflammatory skin diseases, for example atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. Thus, prednicarbate may be a consideration in the treatment of atopic dermatitis in children, and other inflammatory disorders in children and adults.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Prednicarbate for system suitability A, European Pharmacopoeia (EP) Reference Standard
Prednicarbate, European Pharmacopoeia (EP) Reference Standard